having alpha [RSABE / ABEL]

posted by martin  – Austria, 2013-03-28 16:08 (4483 d 07:24 ago) – Posting: # 10304
Views: 25,462

Hi Helmut & simulants !

What do you think about a kind of adaptive group-sequential design with one interim analysis (i.e. estimate CV) allowing to make a decision regarding average BE or scaled BE in the final analysis? This may solve the problem.

best regards

martin

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,679 registered users;
34 visitors (0 registered, 34 guests [including 11 identified bots]).
Forum time: 00:33 CEST (Europe/Vienna)

Many people tend to look at programming styles and languages like religions:
if you belong to one, you cannot belong to others.
But this analogy is another fallacy.    Niklaus Wirth

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5